Willaertia magna C2c Maky (Human Health)
Prevention/Treatment of Bacterial Biofilms
ResearchExploratory
Key Facts
Indication
Prevention/Treatment of Bacterial Biofilms
Phase
Research
Status
Exploratory
Company
About Amoeba S.A.
Amoeba S.A. leverages its proprietary amoeba-based platform to create novel biocontrol agents targeting major agricultural pests and exploring applications in human health. The company's lead candidate, Lys Amoéba, is a biocontrol fungicide/bactericide derived from Willaertia magna C2c Maky, aimed at reducing chemical pesticide use in agriculture. Amoeba is a publicly traded company focused on providing sustainable, biological alternatives in the growing agri-tech market, with its research and development operations based in Chassieu, France.
View full company profile